©The Author(s) 2016.
World J Gastroenterol. Aug 28, 2016; 22(32): 7186-7202
Published online Aug 28, 2016. doi: 10.3748/wjg.v22.i32.7186
Published online Aug 28, 2016. doi: 10.3748/wjg.v22.i32.7186
Table 3 Role of probiotics in irritable bowel syndrome
| Ref. | Diagnostic criteria | No. participant | Probiotic | Time (wk) | Results (vs placebo) |
| O’Sullivan et al[147] | Rome | 25 | Lactobacillus GG | 20 | No difference |
| Nobaek et al[148] | Rome | 60 | L. plantarum | 4 | ↓ pain and flatulence |
| Kim et al[149] | Rome II | 25 | VSL#3 | 8 | ↓ bloating |
| O’Mahony et al[150] | Rome II | 80 | L. salivarius UCC4331, B. infantis 35624 | 8 | ↓ symptoms and pro-inflammatory cytokines (only for B. infantis) |
| Kajarder et al[151] | Rome/Rome II | 103 | Mixture of L. rhamnosus GG, L. rhamnosus LC705, B. breve Bb99, P. freudenreichii | 24 | ↓ symptoms |
| Kim et al[152] | Rome II | 48 | VSL#3 | 8 | ↓ flatulence |
| Niv et al[153] | Rome II | 54 | L. reuteri ATCC55730 | 24 | No difference |
| Whorwell et al[154] | Rome II | 362 | B. infantis 35624 | 4 | ↓ symptoms (only at dose of 1 × 108 CFU) |
| Guyonnet et al[155] | Rome II (C-IBS) | 274 | B. animalis DN173010 | 4 | ↑ QoL and bloating score |
| Kajander et al[156] | Rome II | 86 | L. rhamnosus GG, L. rhamnosus Lc705, P. freudenreichii sp P. Shermanii JS, B. animalis sp P. lactis Bb-12 | 20 | ↓ bloating and abdominal pain |
| Zeng et al[157] | Rome II (D-IBS) | 29 | S. thermophilus, L. bulgaricus, B. longum | 4 | ↓intestinal permeability and symptoms |
| Drouault-Holowazcz et al[158] | Rome II | 100 | B. longum LA101, L. acidophilus LA102, Lactocuccus lactis LA103, S. thermophilus LA104 | 4 | ↑ QoL |
| ↓ flatulence, pain and bloating | |||||
| Sinn et al[159] | Roma III | 40 | L. acidophilus SDC 2012, 2013 | 4 | ↓ symptoms |
| Simrén et al[160] | Rome II | 74 | L. paracasei F19, L. acidophilus La5, B. lactis Bb-12 | 8 | No difference |
| Søndergaard et al[161] | Rome II | 52 | L. paracasei F19, L. acidophilus La5, B. lactis Bb-12 | 8 | No difference |
| Guglielmetti et al[162] | Rome III | 122 | B. bifidum MIMBb75 | 4 | ↓ symptoms ↑ QoL |
| Ducrotté et al[163] | Rome III (D-IBS) | 214 | L. plantarum 299v | 4 | ↓ pain and bloating |
| Kruis et al[164] | Rome II (D-IBS) | 120 | E. coli Nissle 1917 | 12 | No difference |
| Ki Cha et al[165] | Roma III (D-IBS) | 50 | L. acidophilus, L. plantarum, L. rhamnosus, B. breve, B. lactis, B. longum, S.thermophilus | 8 | ↑ QoL |
| Dapoigny et al[166] | Rome III | 50 | L. caseirhamnosus | 4 | ↓ symptoms |
| Roberts et al[167] | Rome III | 179 | B. lactis CNCMI-2494 | 12 | No difference |
| Shavatehi et al[168] | Rome II | 160 | Lactobacillus, Bifidobacterium strains and Streptococcus thermophiles | 2 | No difference |
| Yoon et al[169] | Rome III | 80 | L. acidophilus, L. rhamnosus, B. breve, B. actis, B. longum, S.thermophilus | 4 | ↓ symptoms |
| Pineton de Chambrun et al[170] | Rome III | 179 | S. cerevisiae | 8 | ↓ pain and discomfort |
- Citation: Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol 2016; 22(32): 7186-7202
- URL: https://www.wjgnet.com/1007-9327/full/v22/i32/7186.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i32.7186